161 related articles for article (PubMed ID: 18359147)
1. The feasibility of prostate cancer detection by triple spectroscopy.
Salomon G; Hess T; Erbersdobler A; Eichelberg C; Greschner S; Sobchuk AN; Korolik AK; Nemkovich NA; Schreiber J; Herms M; Graefen M; Huland H
Eur Urol; 2009 Feb; 55(2):376-83. PubMed ID: 18359147
[TBL] [Abstract][Full Text] [Related]
2. Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality.
Parekh DJ; Lin WC; Herrell SD
J Urol; 2005 Nov; 174(5):1754-8. PubMed ID: 16217277
[TBL] [Abstract][Full Text] [Related]
3. Light Reflectance Spectroscopy to Detect Positive Surgical Margins on Prostate Cancer Specimens.
Morgan MS; Lay AH; Wang X; Kapur P; Ozayar A; Sayah M; Zeng L; Liu H; Roehrborn CG; Cadeddu JA
J Urol; 2016 Feb; 195(2):479-83. PubMed ID: 26410735
[TBL] [Abstract][Full Text] [Related]
4. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.
Lin DW; Coleman IM; Hawley S; Huang CY; Dumpit R; Gifford D; Kezele P; Hung H; Knudsen BS; Kristal AR; Nelson PS
J Clin Oncol; 2006 Aug; 24(23):3763-70. PubMed ID: 16822846
[TBL] [Abstract][Full Text] [Related]
5. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
Donovan MJ; Hamann S; Clayton M; Khan FM; Sapir M; Bayer-Zubek V; Fernandez G; Mesa-Tejada R; Teverovskiy M; Reuter VE; Scardino PT; Cordon-Cardo C
J Clin Oncol; 2008 Aug; 26(24):3923-9. PubMed ID: 18711180
[TBL] [Abstract][Full Text] [Related]
6. Electrical impedance spectroscopy of the human prostate.
Halter RJ; Hartov A; Heaney JA; Paulsen KD; Schned AR
IEEE Trans Biomed Eng; 2007 Jul; 54(7):1321-7. PubMed ID: 17605363
[TBL] [Abstract][Full Text] [Related]
7. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
8. Genetic and least squares algorithms for estimating spectral EIS parameters of prostatic tissues.
Halter RJ; Hartov A; Paulsen KD; Schned A; Heaney J
Physiol Meas; 2008 Jun; 29(6):S111-23. PubMed ID: 18544804
[TBL] [Abstract][Full Text] [Related]
9. Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer.
Crow P; Molckovsky A; Stone N; Uff J; Wilson B; WongKeeSong LM
Urology; 2005 Jun; 65(6):1126-30. PubMed ID: 15913721
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment on: The feasibility of prostate cancer detection by triple spectroscopy.
Da Pozzo LF
Eur Urol; 2009 Feb; 55(2):383-4. PubMed ID: 18359149
[No Abstract] [Full Text] [Related]
12. Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid--first clinical experiences.
Zaak D; Sroka R; Khoder W; Adam C; Tritschler S; Karl A; Reich O; Knuechel R; Baumgartner R; Tilki D; Popken G; Hofstetter A; Stief CG
Urology; 2008 Aug; 72(2):345-8. PubMed ID: 18405945
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
Adam C; Salomon G; Walther S; Zaak D; Khoder W; Becker A; Reich O; Blana A; Ganzer R; Denzinger S; Popken G; Sroka R; Knüchel-Clarke R; Köllermann J; Sauter G; Hartmann A; Bertz S; Graefen M; Huland H; Wieland W; Stief CG
Eur Urol; 2009 Jun; 55(6):1281-8. PubMed ID: 19328622
[TBL] [Abstract][Full Text] [Related]
14. Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
Rabbani F; Vora KC; Yunis LH; Eastham JA; Guillonneau B; Scardino PT; Touijer K
BJU Int; 2009 Sep; 104(5):605-10. PubMed ID: 19689577
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
18. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
20. Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations.
Seitz M; Bayer T; Ruszat R; Tilki D; Bachmann A; Gratzke C; Schlenker B; Stief C; Sroka R; Reich O
BJU Int; 2009 Mar; 103(6):770-5. PubMed ID: 18990158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
